Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HLA and bone marrow transplantation

T H Eiermann1

  • 1Red Cross Blood Bank, Department of Transplantation Immunology, Ulm, Germany.

Archivum Immunologiae Et Therapiae Experimentalis
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An HLA-DR11/DQ3 haplotype with a DRB1*0301 sequence motif in the third hypervariable region of the HLA-DR beta-1 chain: molecular and serological analysis of its generation in a European Caucasian family.

Tissue antigens·2009
Same author

Successful donor-lymphocyte infusion for extreme immune-hemolysis following unrelated BMT in a patient with X-linked chronic granulomatous disease and McLeod phenotype.

Bone marrow transplantation·2008
Same author

The effect of IgM-enriched human Ig and rabbit antithymocyte globulin on the stimulation of mononuclear cells.

Scandinavian journal of immunology·2002
Same author

Jurkat cell-reactive anti-thymocyte globulin assessed ex vivo by flow cytometry persists three weeks in circulation.

Journal of hematotherapy & stem cell research·2001
Same author

PERB11 (MIC): a polymorphic MHC gene is expressed in skin and single nucleotide polymorphisms are associated with psoriasis.

Clinical and experimental immunology·2000
Same author

Monitoring anti-thymocyte globulin (ATG) in bone marrow recipients.

Bone marrow transplantation·1999

Human leukocyte antigen (HLA) class II typing using molecular methods enhances donor selection for bone marrow transplants. This improves matching for patients needing stem cell transplants, especially when family donors are unavailable.

Area of Science:

  • Immunogenetics
  • Hematology
  • Transplantation Medicine

Background:

  • Bone marrow transplantation (BMT) using HLA-identical siblings is a standard treatment for leukemia and other blood disorders.
  • Unrelated donors are increasingly sought for patients without suitable family donors, necessitating precise donor matching.
  • Human Leukocyte Antigen (HLA) matching is critical for successful BMT outcomes.

Purpose of the Study:

  • To report on advancements in HLA class II typing using molecular techniques.
  • To highlight the impact of improved HLA typing on donor selection processes.
  • To demonstrate the benefits of molecular HLA typing in enhancing BMT matching.

Main Methods:

  • Utilizing advanced molecular methods for high-resolution HLA class II typing.

Related Experiment Videos

  • Implementing these typing techniques in donor searches for BMT recipients.
  • Analyzing the impact of molecular typing on the accuracy of HLA matching.

    • Main Results:

    • Molecular methods provide enhanced resolution for HLA class II typing compared to older techniques.
    • Improved HLA class II matching has been achieved through the application of these molecular methods.
    • The donor search process has been significantly influenced, leading to better donor-recipient pairings.

    Conclusions:

    • Molecular HLA class II typing is crucial for optimizing donor selection in bone marrow transplantation.
    • These advancements improve the likelihood of successful engraftment and reduce transplant-related complications.
    • The use of molecular typing is essential for expanding the donor pool and improving outcomes for patients.